Safety of dupilumab in Chinese pediatric patients aged 6 months and older: a prospective real-world study

Safety of dupilumab in Chinese pediatric patients aged 6 months and older: a prospective real-world study

ObjectiveThis study analyzes the occurrence and characteristics of adverse drug reactions (ADRs) of dupilumab in children in a real-world setting. It aims to enhance clinical practice and minimize medication safety risks in pediatric patients.MethodsThis prospective study included children receiving...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanhua Chen, Jiang Ni, Ming Li, Yuan Hong, Kouzhu Zhu, Rong Hong, Li Deng, Zhijie Li, Jie Pu, Ting Yang, Yan Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pediatrics
Subjects:
children
dupilumab
real world
safety
adverse drug reactions
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2024.1524962/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items